SCHEMBL2198025

SCHEMBL2198025

COCCNS(=O)(=O)c1ccc(C)c(C(=O)c2ccc(Nc3ccc(F)cc3F)cc2Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 6/20 0.51
MAPK13 O15264 5/20 0.51
MAPK12 P53778 5/20 0.51
MAPK11 Q15759 5/20 0.51
MAPT P10636 5/20 0.46
LMNA P02545 3/20 0.46
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 2/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
ALDH1A1 P00352 2/20 0.40
TP53 P04637 2/20 0.40
USP2 O75604 1/20 0.40
GLA P06280 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2196354 0.91 MAPK13 (0.53) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2198904 0.91 MAPK13 (0.53) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2197683 0.88 MAPK13 (0.51) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2198977 0.85 MAPK13 (0.52) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2196867 0.84 MAPK14 (0.50) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2198207 0.84 MAPK13 (0.60) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2199318 0.83 ALDH1A1 (0.51) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL12164686 0.82 MAPK13 (0.52) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2198811 0.81 MAPK13 (0.54) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2200365 0.80 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US claimed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP claimed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK14 697/4885MAPK13 1063/4885MAPK12 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.